← back to search

Sarah Walter

University of Southern California · US
Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies, and Migraine and Headache Studies.
h-index
60
citations
13,718
works
199
NIH funding
primary concept
email

Recent publications

Relationships of PGRN with sTREM2 in AD continuum and non-AD pathophysiology and their reciprocal roles in modulating amyloid pathology: two population-based study
Translational Psychiatry 2025cited by 3position: middledoi
Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort
Scientific Reports 2024cited by 26position: middledoi
A novel spatiotemporal graph convolutional network framework for functional connectivity biomarkers identification of Alzheimer’s disease
Alzheimer s Research & Therapy 2024cited by 17position: middledoi
Enhancing cognitive performance prediction by white matter hyperintensity connectivity assessment
Brain 2024cited by 15position: middledoi
Global rural health disparities in Alzheimer's disease and related dementias: State of the science
Alzheimer s & Dementia 2023cited by 88position: middledoi
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease
JAMA Neurology 2023cited by 84position: middledoi
Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction
Communications Medicine 2023cited by 69position: middledoi
Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis
Brain 2023cited by 46position: middledoi
Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
JAMA Neurology 2023cited by 43position: middledoi
Sex-specific modulation of amyloid-β on tau phosphorylation underlies faster tangle accumulation in females
Brain 2023cited by 40position: middledoi
The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease
Alzheimer s & Dementia 2022cited by 246position: middledoi
Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression
JAMA Psychiatry 2022cited by 145position: middledoi
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Nature Communications 2022cited by 129position: middledoi
An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease
Nature Aging 2022cited by 46position: middledoi
Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease
Nature Communications 2022cited by 43position: middledoi
The trend of disruption in the functional brain network topology of Alzheimer’s disease
Scientific Reports 2022cited by 40position: middledoi
The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores
Communications Biology 2022cited by 16position: middledoi
The nutritional impact of a feeding protocol for infants on high flow nasal cannula therapy
Nutrition in Clinical Practice 2022cited by 7position: firstdoi
The nutritional impact of a feeding protocol for infants on high flow nasal cannula therapy.
2022cited by 6position: contributordoi
Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease
JAMA Neurology 2021cited by 319position: middledoi
Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease
Nature Communications 2021cited by 100position: middledoi
A deep learning framework identifies dimensional representations of Alzheimer’s Disease from brain structure
Nature Communications 2021cited by 99position: middledoi
Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
Translational Psychiatry 2021cited by 69position: middledoi
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
Translational Psychiatry 2021cited by 68position: middledoi
KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease
Nature Communications 2021cited by 67position: middledoi
Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization
Scientific Reports 2021cited by 31position: middledoi
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
Nature Communications 2020cited by 534position: middledoi
Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease
Nature Communications 2020cited by 339position: middledoi
Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology
Scientific Reports 2020cited by 134position: middledoi
Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau
Brain Communications 2020cited by 85position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Marcelo E. Bigal · Dartmouth College3 papers (2013–2016)Alan M. Rapoport · University of California, Los Angeles2 papers (2013–2015)Jin Dong · AstraZeneca (Australia)1 papers (2013–2013) · 1 papers (2022–2022)Nathan Eyde · University of Arizona1 papers (2016–2016)Hartmut Goldschmidt · Virginia Cooperative Extension1 papers (2020–2020)David W. Dodick · New York Academy of Medicine1 papers (2016–2016)Tobias Terzer · German Cancer Research Center1 papers (2020–2020)Christina Kunz · Max Rubner Institut1 papers (2020–2020)Dirk B. Mendel · Spark Therapeutics (United States)1 papers (2013–2013)M. Connor Garbe · University of Oklahoma Health Sciences Center1 papers (2022–2022)Rema Raman · ADS Group1 papers (2022–2022)Jennifer Y. Xie · University of Arizona1 papers (2016–2016)Marc S. Raab · Memorial Sloan Kettering Cancer Center1 papers (2020–2020)Frank Porreca · University of Arizona1 papers (2016–2016)Chad J. Swanson · Prothena (United States)1 papers (2022–2022)Jonathan P. Walther · University of Oklahoma Health Sciences Center1 papers (2022–2022) · 1 papers (2022–2022)Rudolf Schlag · Universitätsklinikum Würzburg1 papers (2020–2020)Tom Hunter · Amgen (United States)1 papers (2013–2013)